Sr. Engineering Director- Portfolio Leader- Cardiac Surgery (CS) and Aortic (A)

We anticipate the application window for this opening will close on - 17 Apr 2026 At Medtronic you can begin a life-long career of exploration and innovation, while helping champion healthcare access and equity for all. You’ll lead with purpose, breaking down barriers to innovation in a more connected, compassionate world. A Day in the Life The Sr Engineering Director position has the primary responsibility, ownership and authority as the portfolio leader of the Cardiac Surgery (CS) surgical valve, ECLS and atrial fibrillation therapies. Reporting to the R&D VP, this position will partner with the CS leadership team to develop and implement an overarching vision and strategy for product development within CS. This individual manages the R&D therapy leaders in the Surgical Valve, Atrial Fibrillation and ECLS technology organizations and drive accountability, ownership and execution of the Product Development process and deliverables. This position will be critical in the development and deployment of strategy that aligns with the CS strategies and initiatives to ensure new products are delivered on time and meet functional and operational goals including Quality, Manufacturability, Performance, Cost and Flawless Launch. Key partners and stakeholders include Operations, Marketing, Quality Assurance, Regulatory, Sourcing, Supply Chain, Contract Manufacturing, Finance and other CS functions as required. We are seeking a seasoned Senior Engineering Director to lead the Cardiac Surgery (CS) portfolio focused on valve disease, atrial fibrillation and ECLS therapies.  Reporting to the R&D Vice President, this position will be responsible to develop and implement an overarching vision and strategy for CS product portfolio.  This individual will oversee the Surgical Valve, ECLS and AF technology organizations and drive accountability, ownership and execution of the product development process and deliverables, raising expectations on the application of DRM and EUMDR to anticipate and respond quickly to the needs of the business. As the Cardiac Surgery portfolio leader, you will serve as the strategic glue between development activities, programs, and business needs. You will develop and deploy strategies that aligns with the CS Objectives and its operations strategies and initiatives and ensure new products are delivered on time and meet functional and operational goals including Quality, Manufacturability, Performance, Cost and Flawless Launch. This requires you to navigate deep technical interdependencies, influence related business development cycle, product requirements, and provide the overarching coordination necessary to deliver the next generation of life saving cardiac devices. Key partners and stakeholders include Operations, Marketing, Quality Assurance, Regulatory, Sourcing, Supply Chain, Contract Manufacturing, Finance and other CS functions as required. Key Responsibilities: Strategic Oversight:  Plans, directs and implements all aspects of Cardiac Surgery product portfolio and development of medical device products.  Lead the R&D therapy leaders / teams through the evaluation, development, and lifecycle management of large-scale projects. Operational Excellence : Drive improved process development capabilities to support new product development and product launches. Serve as the primary liaison between project planning and execution teams to ensure seamless delivery across hardware and software disciplines. Portfolio Governance : Establish objectives, timelines, milestones, and budgets for multiple therapies.  Assume Financial stewardship of the portfolio. Budget and manage operating expenses and enforce appropriate cost controls and financial discipline. Risk & Resolution : Identify complex, undefined issues that impact multiple business therapies. Use significant conceptualization and reasoning skills to develop resolutions that meet productivity and quality goals. Executive Influence:  Act as a principal sp ... (truncated, view full listing at source)